Based on 2 analysts offering 12 month price targets for Cassava Sciences Inc
Min Forecast
$107.00+4,613.66%
Avg Forecast
$111.50+4,811.89%
Max Forecast
$116.00+5,010.13%
Should I buy or sell SAVA stock?
Based on 2 analysts offering ratings for Cassava Sciences Inc.
Buy
Strong Buy
1 analysts 50%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SAVA's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates SAVA as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More
Be the first to know when Wall Street analysts revise their SAVA stock forecasts and price targets.
Is Cassava Sciences Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: SAVA) stock is to Buy SAVA stock.
Out of 2 analysts, 1 (50%) are recommending SAVA as a Strong Buy, 0 (0%) are recommending SAVA as a Buy, 1 (50%) are recommending SAVA as a Hold, 0 (0%) are recommending SAVA as a Sell, and 0 (0%) are recommending SAVA as a Strong Sell.
What is SAVA's earnings growth forecast for 2025-2025?
(NASDAQ: SAVA) Cassava Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.5%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.57%.
Cassava Sciences's earnings in 2025 is -$17,664,000.
In 2025, SAVA is forecast to generate -$29,828,495 in earnings, with the lowest earnings forecast at -$29,828,495 and the highest earnings forecast at -$29,828,495.
What is SAVA's revenue growth forecast for 2025-2025?
(NASDAQ: SAVA) Cassava Sciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 49.13%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.68%.
Cassava Sciences's revenue in 2025 is $0.
In 2025, SAVA is forecast to generate $4,811,047,500 in revenue, with the lowest revenue forecast at $4,811,047,500 and the highest revenue forecast at $4,811,047,500.
What is SAVA's forecast return on assets (ROA) for 2025-2028?
(NASDAQ: SAVA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 34.69%.
What is SAVA's Price Target?
According to 2 Wall Street analysts that have issued a 1 year SAVA price target, the average SAVA price target is $111.50, with the highest SAVA stock price forecast at $116.00 and the lowest SAVA stock price forecast at $107.00.
On average, Wall Street analysts predict that Cassava Sciences's share price could reach $111.50 by Nov 26, 2025. The average Cassava Sciences stock price prediction forecasts a potential upside of 4,811.89% from the current SAVA share price of $2.27.
What is SAVA's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: SAVA) Cassava Sciences's current Earnings Per Share (EPS) is -$0.37. In 2025, SAVA's EPS is forecast to hit -$0.62 (min: -$0.62, max: -$0.62).
What is SAVA's forecast return on equity (ROE) for 2025-2028?
(NASDAQ: SAVA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.